Tyme科技

TYME NASDAQ
1.230
-0.030
-2.38%
盘后: 1.230 0 0.00% 17:04 07/19 EDT
开盘
1.250
昨收
1.260
最高
1.260
最低
1.230
成交量
29.90万
成交均量(3M)
84.01万
52周最高
4.642
52周最低
0.9200
换手率
0.27%
市值
1.38亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Tyme科技 TYME股票价格,Tyme科技股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Tyme Technologies, Inc. is a clinical-stage biotechnology company. The Company is focused on developing cancer therapeutics that is intended to be broadly effective across tumor types and have low toxicity profiles. The Company’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic weaknesses to compromise its defenses, leading to cell death through oxidative stress and exposure to the body’s natural immune system. The Company’s lead clinical program, SM-88, is a first-in-class combination therapy in Phase II development for prostate cancer, and it is preparing to initiate an additional Phase II clinical trial for pancreatic cancer. The Company provides a novel compound for physicians to use in a treatment regimen for patients fighting six major cancers including breast, lung, prostate, gastric, esophageal and pancreatic cancers.
展开 >

最近浏览

名称
价格
涨跌幅